Xilio Therapeutics (XLO) Times Interest Earned (2020 - 2022)

Xilio Therapeutics has disclosed Times Interest Earned across 3 years of filings, most recently posting -$164.53 for Q1 2022.

• Times Interest Earned for Q1 2022 came in at -$164.53, down 46.4% year-over-year; the trailing twelve-month figure through Dec 2022 was -$691.08 (down 435.96% YoY), and the FY2021 annual result was -$99.26, down 19.34% from the prior year.
• Times Interest Earned came in at -$164.53 for Q1 2022 at Xilio Therapeutics, down from -$134.87 in the prior quarter.
• In the past five years, Times Interest Earned ranged from a high of -$55.04 in Q3 2021 to a low of -$164.53 in Q1 2022.
• The 3-year median for Times Interest Earned is -$114.37 (2021), against an average of -$109.63.
• Across the five-year window, Times Interest Earned grew 26.23% in 2021 and sank 46.4% in 2022, its largest moves.
• Xilio Therapeutics' Times Interest Earned stood at -$116.36 in 2020, then dropped by 15.91% to -$134.87 in 2021, then slipped by 21.99% to -$164.53 in 2022.
• The last three Times Interest Earned figures came in at -$164.53 (Q1 2022), -$134.87 (Q4 2021), and -$55.04 (Q3 2021), per Business Quant data.